Trial intelligence / Profile preview

Dupuytren's interventions surgery vs collagenase

ISRCTN18254597Phase 4Completed

Sponsor
University Hospitals of Leicester NHS Trust
Start
May 2017
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
01

Overview

Phase 4, randomised, open-label trial of collagenase clostridium histolyticum in Dupuytren's contracture (2 arms), sponsored by University Hospitals of Leicester NHS Trust. Primary endpoint: Hand health and overall hand assessment. Started May 2017; status: completed.

02

Drugs

collagenase clostridium histolyticum
03

Conditions

Dupuytren's contracture

Beyond the preview

Go deeper on ISRCTN18254597.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN18254597.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call